Amylyx Pharmaceuticals IncNASDAQ:AMLX
No Matches were found for
- LAST PRICE1.7600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.7500/ 3
- Ask / Lots1.7600/ 6
- Open / Previous Close1.7600 / 1.7600
- Day Range
- 52 Week Range
- Volume1,259,228
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMLX |
|---|---|---|
| 09:32 ET | 40432 | 1.74 |
| 09:34 ET | 53514 | 1.7 |
| 09:36 ET | 8423 | 1.705 |
| 09:38 ET | 1590 | 1.705 |
| 09:39 ET | 15227 | 1.7 |
| 09:41 ET | 2709 | 1.6994 |
| 09:43 ET | 24337 | 1.695 |
| 09:45 ET | 4715 | 1.69 |
| 09:48 ET | 590 | 1.69 |
| 09:50 ET | 32688 | 1.715 |
| 09:52 ET | 11288 | 1.72 |
| 09:54 ET | 4145 | 1.74 |
| 09:56 ET | 1800 | 1.736 |
| 09:57 ET | 11806 | 1.75 |
| 09:59 ET | 1950 | 1.755 |
| 10:01 ET | 23442 | 1.76 |
| 10:03 ET | 400 | 1.76 |
| 10:06 ET | 1386 | 1.755 |
| 10:08 ET | 8842 | 1.765 |
| 10:10 ET | 1338 | 1.7695 |
| 10:12 ET | 15245 | 1.76 |
| 10:14 ET | 15518 | 1.76 |
| 10:15 ET | 19851 | 1.74 |
| 10:17 ET | 25834 | 1.7301 |
| 10:19 ET | 1100 | 1.73 |
| 10:21 ET | 4485 | 1.73 |
| 10:24 ET | 3556 | 1.73 |
| 10:26 ET | 23481 | 1.745 |
| 10:28 ET | 10307 | 1.735 |
| 10:30 ET | 292 | 1.7303 |
| 10:33 ET | 300 | 1.735 |
| 10:35 ET | 1906 | 1.73 |
| 10:37 ET | 2100 | 1.739 |
| 10:39 ET | 20628 | 1.755 |
| 10:42 ET | 1889 | 1.76 |
| 10:44 ET | 2291 | 1.7501 |
| 10:46 ET | 15439 | 1.765 |
| 10:48 ET | 341 | 1.77 |
| 10:50 ET | 5100 | 1.77 |
| 10:51 ET | 1068 | 1.77 |
| 10:53 ET | 500 | 1.7606 |
| 10:55 ET | 1487 | 1.76 |
| 10:57 ET | 3400 | 1.76 |
| 11:00 ET | 400 | 1.765 |
| 11:02 ET | 1104 | 1.76 |
| 11:04 ET | 3258 | 1.76 |
| 11:06 ET | 900 | 1.76 |
| 11:08 ET | 4100 | 1.76 |
| 11:09 ET | 3300 | 1.76 |
| 11:11 ET | 600 | 1.76 |
| 11:13 ET | 2414 | 1.76 |
| 11:15 ET | 800 | 1.76 |
| 11:18 ET | 1300 | 1.765 |
| 11:20 ET | 2045 | 1.76 |
| 11:22 ET | 2882 | 1.76 |
| 11:24 ET | 600 | 1.765 |
| 11:26 ET | 700 | 1.76 |
| 11:27 ET | 500 | 1.765 |
| 11:29 ET | 12839 | 1.75 |
| 11:31 ET | 3185 | 1.75 |
| 11:33 ET | 4298 | 1.745 |
| 11:36 ET | 1000 | 1.7403 |
| 11:38 ET | 700 | 1.74 |
| 11:40 ET | 1185 | 1.7402 |
| 11:42 ET | 900 | 1.74 |
| 11:44 ET | 800 | 1.74 |
| 11:45 ET | 1389 | 1.74 |
| 11:47 ET | 800 | 1.74 |
| 11:49 ET | 1400 | 1.74 |
| 11:51 ET | 800 | 1.745 |
| 11:54 ET | 600 | 1.74 |
| 11:56 ET | 722 | 1.74 |
| 11:58 ET | 2578 | 1.745 |
| 12:00 ET | 1000 | 1.74 |
| 12:02 ET | 1001 | 1.745 |
| 12:03 ET | 600 | 1.74 |
| 12:05 ET | 800 | 1.74 |
| 12:07 ET | 3298 | 1.74 |
| 12:09 ET | 1100 | 1.74 |
| 12:12 ET | 600 | 1.74 |
| 12:14 ET | 500 | 1.74 |
| 12:16 ET | 200 | 1.74 |
| 12:18 ET | 1500 | 1.74 |
| 12:20 ET | 1100 | 1.745 |
| 12:21 ET | 4800 | 1.745 |
| 12:23 ET | 2510 | 1.74 |
| 12:25 ET | 729 | 1.745 |
| 12:27 ET | 1288 | 1.74 |
| 12:30 ET | 700 | 1.745 |
| 12:32 ET | 500 | 1.74 |
| 12:34 ET | 1429 | 1.7494 |
| 12:36 ET | 800 | 1.745 |
| 12:38 ET | 785 | 1.74 |
| 12:39 ET | 908 | 1.7406 |
| 12:41 ET | 871 | 1.74 |
| 12:45 ET | 2050 | 1.75 |
| 12:48 ET | 1000 | 1.74 |
| 12:50 ET | 9535 | 1.735 |
| 12:52 ET | 12999 | 1.72 |
| 12:54 ET | 400 | 1.72 |
| 12:56 ET | 1930 | 1.72 |
| 12:57 ET | 7549 | 1.72 |
| 12:59 ET | 711 | 1.72 |
| 01:01 ET | 10803 | 1.725 |
| 01:03 ET | 2446 | 1.7298 |
| 01:06 ET | 2222 | 1.73 |
| 01:08 ET | 1600 | 1.72 |
| 01:10 ET | 1700 | 1.72 |
| 01:12 ET | 800 | 1.725 |
| 01:14 ET | 1200 | 1.72 |
| 01:15 ET | 800 | 1.725 |
| 01:17 ET | 226 | 1.7294 |
| 01:19 ET | 18835 | 1.735 |
| 01:21 ET | 5957 | 1.73 |
| 01:24 ET | 300 | 1.725 |
| 01:28 ET | 10629 | 1.735 |
| 01:30 ET | 300 | 1.735 |
| 01:32 ET | 1100 | 1.735 |
| 01:33 ET | 2456 | 1.7394 |
| 01:35 ET | 100 | 1.735 |
| 01:37 ET | 1230 | 1.735 |
| 01:39 ET | 1600 | 1.735 |
| 01:44 ET | 100 | 1.74 |
| 01:46 ET | 584 | 1.735 |
| 01:48 ET | 1410 | 1.735 |
| 01:50 ET | 200 | 1.735 |
| 01:51 ET | 150 | 1.7399 |
| 01:53 ET | 200 | 1.735 |
| 01:55 ET | 1968 | 1.735 |
| 01:57 ET | 2356 | 1.735 |
| 02:00 ET | 100 | 1.73 |
| 02:02 ET | 600 | 1.735 |
| 02:04 ET | 2314 | 1.73 |
| 02:06 ET | 500 | 1.73 |
| 02:08 ET | 8338 | 1.725 |
| 02:09 ET | 1951 | 1.72 |
| 02:11 ET | 400 | 1.72 |
| 02:13 ET | 978 | 1.7294 |
| 02:15 ET | 700 | 1.72 |
| 02:18 ET | 600 | 1.72 |
| 02:20 ET | 416 | 1.7294 |
| 02:22 ET | 885 | 1.72 |
| 02:24 ET | 3338 | 1.725 |
| 02:26 ET | 1000 | 1.725 |
| 02:27 ET | 500 | 1.725 |
| 02:29 ET | 400 | 1.725 |
| 02:31 ET | 600 | 1.725 |
| 02:33 ET | 200 | 1.725 |
| 02:36 ET | 761 | 1.725 |
| 02:38 ET | 500 | 1.725 |
| 02:40 ET | 5824 | 1.725 |
| 02:42 ET | 685 | 1.725 |
| 02:44 ET | 1300 | 1.725 |
| 02:45 ET | 100 | 1.72 |
| 02:47 ET | 6906 | 1.72 |
| 02:49 ET | 1089 | 1.72 |
| 02:51 ET | 1100 | 1.72 |
| 02:54 ET | 15213 | 1.71 |
| 02:56 ET | 52969 | 1.7399 |
| 03:00 ET | 1200 | 1.74 |
| 03:02 ET | 2000 | 1.73 |
| 03:03 ET | 10003 | 1.73 |
| 03:05 ET | 2732 | 1.73 |
| 03:07 ET | 1475 | 1.73 |
| 03:09 ET | 1100 | 1.74 |
| 03:12 ET | 1047 | 1.735 |
| 03:14 ET | 3800 | 1.735 |
| 03:16 ET | 2900 | 1.735 |
| 03:18 ET | 1655 | 1.735 |
| 03:20 ET | 1191 | 1.73 |
| 03:21 ET | 22732 | 1.75 |
| 03:23 ET | 200 | 1.75 |
| 03:25 ET | 200 | 1.75 |
| 03:27 ET | 581 | 1.75 |
| 03:30 ET | 1500 | 1.745 |
| 03:32 ET | 2317 | 1.75 |
| 03:34 ET | 11918 | 1.745 |
| 03:36 ET | 1500 | 1.745 |
| 03:38 ET | 1800 | 1.745 |
| 03:39 ET | 1064 | 1.745 |
| 03:41 ET | 11335 | 1.745 |
| 03:43 ET | 1872 | 1.745 |
| 03:45 ET | 1567 | 1.745 |
| 03:48 ET | 3867 | 1.745 |
| 03:50 ET | 45619 | 1.73 |
| 03:52 ET | 7447 | 1.73 |
| 03:54 ET | 5843 | 1.74 |
| 03:56 ET | 56377 | 1.74 |
| 03:57 ET | 16982 | 1.74 |
| 03:59 ET | 181390 | 1.76 |
Jun 4, 2024
Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 9:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
9:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
May 31, 2024
Lifshitz Law PLLC Announces Investigations of Cassava Sciences, Inc. (NASDAQ: SAVA), iRhythm Technologies, Inc. (NASDAQ: IRTC), Xponential Fitness, Inc. (NYSE: XPOF), and Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), from 11:01PM ET on Friday May 31, 2024 by Dow Jones
11:01PM ET on Friday May 31, 2024 by Dow Jones
May 14, 2024
DJ Amylyx Pharmaceuticals Is Maintained at Neutral by Mizuho, from 6:57AM ET on Tuesday May 14, 2024 by Dow Jones
6:57AM ET on Tuesday May 14, 2024 by Dow Jones
May 10, 2024
DJ Amylyx Pharmaceuticals Price Target Maintained With a $8.00/Share by HC Wainwright & Co., from 8:35AM ET on Friday May 10, 2024 by Dow Jones
8:35AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
Press Release: Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results, from 7:01AM ET on Thursday May 09, 2024 by Dow Jones
7:01AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amylyx Pharmaceuticals Inc | 117.0M | -1.6x | --- |
Organogenesis Holdings Inc | 364.6M | 61.6x | --- |
Amarin Corporation PLC | 355.4M | -5.5x | --- |
Coherus BioSciences Inc | 208.8M | -2.2x | --- |
Sinovac Biotech Ltd | 639.9M | -6.0x | --- |
Invitae Corp | 229.2K | 0.0x | --- |
Company Information
No data available
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $117.0M |
|---|---|
Revenue (TTM) | $398.0M |
Shares Outstanding | 68.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $6.40 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
